Nothing
tests/testthat/_snaps/aet01.md
In chevron: Standard TLGs for Clinical Trials Reporting
aet01 can handle all NA values
Code
cat(export_as_txt(res, lpp = 100))
Output
A: Drug X B: Placebo C: Combination
(N=15) (N=15) (N=15)
—————————————————————————————————————————————————————————————————————————————————————————————————————
Total number of patients with at least one AE 13 (86.7%) 14 (93.3%) 15 (100%)
Total number of AEs 58 59 99
Total number of deaths 2 (13.3%) 4 (26.7%) 3 (20.0%)
Total number of patients withdrawn from study due to an AE 0 0 1 (6.7%)
Total number of patients with at least one
AE with fatal outcome 0 0 0
Serious AE 0 0 0
Serious AE leading to withdrawal from treatment 0 0 0
Serious AE leading to dose modification/interruption 0 0 0
Related Serious AE 0 0 0
AE leading to withdrawal from treatment 2 (13.3%) 3 (20.0%) 3 (20.0%)
AE leading to dose modification/interruption 6 (40.0%) 9 (60.0%) 11 (73.3%)
Related AE 11 (73.3%) 10 (66.7%) 13 (86.7%)
Related AE leading to withdrawal from treatment 0 3 (20.0%) 0
Related AE leading to dose modification/interruption 1 (6.7%) 4 (26.7%) 9 (60.0%)
Severe AE (at greatest intensity) 11 (73.3%) 10 (66.7%) 12 (80.0%)
Code
cat(export_as_txt(res, lpp = 100))
Output
A: Drug X B: Placebo C: Combination
(N=15) (N=15) (N=15)
—————————————————————————————————————————————————————————————————————————————————————————————————————
Total number of patients with at least one AE 13 (86.7%) 14 (93.3%) 15 (100%)
Total number of AEs 58 59 99
Total number of deaths 2 (13.3%) 4 (26.7%) 3 (20.0%)
Total number of patients withdrawn from study due to an AE 0 0 1 (6.7%)
Total number of patients with at least one
AE leading to withdrawal from treatment 2 (13.3%) 3 (20.0%) 3 (20.0%)
AE leading to dose modification/interruption 6 (40.0%) 9 (60.0%) 11 (73.3%)
Related AE 11 (73.3%) 10 (66.7%) 13 (86.7%)
Related AE leading to withdrawal from treatment 0 3 (20.0%) 0
Related AE leading to dose modification/interruption 1 (6.7%) 4 (26.7%) 9 (60.0%)
Severe AE (at greatest intensity) 11 (73.3%) 10 (66.7%) 12 (80.0%)
aet01 can handle some NA values
Code
cat(export_as_txt(res, lpp = 100))
Output
A: Drug X B: Placebo C: Combination
(N=15) (N=15) (N=15)
—————————————————————————————————————————————————————————————————————————————————————————————————————
Total number of patients with at least one AE 13 (86.7%) 14 (93.3%) 15 (100%)
Total number of AEs 58 59 99
Total number of deaths 2 (13.3%) 4 (26.7%) 3 (20.0%)
Total number of patients withdrawn from study due to an AE 0 0 1 (6.7%)
Total number of patients with at least one
AE with fatal outcome 8 (53.3%) 8 (53.3%) 10 (66.7%)
Serious AE 12 (80.0%) 12 (80.0%) 11 (73.3%)
Serious AE leading to withdrawal from treatment 0 0 2 (13.3%)
Serious AE leading to dose modification/interruption 4 (26.7%) 3 (20.0%) 4 (26.7%)
Related Serious AE 8 (53.3%) 8 (53.3%) 10 (66.7%)
AE leading to withdrawal from treatment 2 (13.3%) 3 (20.0%) 3 (20.0%)
AE leading to dose modification/interruption 6 (40.0%) 9 (60.0%) 11 (73.3%)
Related AE 11 (73.3%) 10 (66.7%) 13 (86.7%)
Related AE leading to withdrawal from treatment 0 3 (20.0%) 0
Related AE leading to dose modification/interruption 1 (6.7%) 4 (26.7%) 9 (60.0%)
Severe AE (at greatest intensity) 11 (73.3%) 10 (66.7%) 12 (80.0%)
aet01 can use custom anl_vars
Code
cat(export_as_txt(res, lpp = 100))
Output
A: Drug X B: Placebo C: Combination
(N=15) (N=15) (N=15)
—————————————————————————————————————————————————————————————————————————————————————————————————————
Total number of patients with at least one AE 13 (86.7%) 14 (93.3%) 15 (100%)
Total number of AEs 58 59 99
Total number of deaths 2 (13.3%) 4 (26.7%) 3 (20.0%)
Total number of patients withdrawn from study due to an AE 0 0 1 (6.7%)
Total number of patients with at least one
AE with fatal outcome 8 (53.3%) 8 (53.3%) 10 (66.7%)
aet01 can use custom medconcept_var
Code
cat(export_as_txt(res, lpp = 100))
Output
A: Drug X B: Placebo C: Combination
(N=15) (N=15) (N=15)
—————————————————————————————————————————————————————————————————————————————————————————————————————
Total number of patients with at least one AE 13 (86.7%) 14 (93.3%) 15 (100%)
Total number of AEs 58 59 99
Total number of deaths 2 (13.3%) 4 (26.7%) 3 (20.0%)
Total number of patients withdrawn from study due to an AE 0 0 1 (6.7%)
Total number of patients with at least one
AE with fatal outcome 8 (53.3%) 8 (53.3%) 10 (66.7%)
Serious AE 12 (80.0%) 12 (80.0%) 11 (73.3%)
Serious AE leading to withdrawal from treatment 0 0 2 (13.3%)
Serious AE leading to dose modification/interruption 4 (26.7%) 3 (20.0%) 4 (26.7%)
Related Serious AE 8 (53.3%) 8 (53.3%) 10 (66.7%)
AE leading to withdrawal from treatment 2 (13.3%) 3 (20.0%) 3 (20.0%)
AE leading to dose modification/interruption 6 (40.0%) 9 (60.0%) 11 (73.3%)
Related AE 11 (73.3%) 10 (66.7%) 13 (86.7%)
Related AE leading to withdrawal from treatment 0 3 (20.0%) 0
Related AE leading to dose modification/interruption 1 (6.7%) 4 (26.7%) 9 (60.0%)
Severe AE (at greatest intensity) 11 (73.3%) 10 (66.7%) 12 (80.0%)
Total number of patients with at least one
SMQ 01 10 (66.7%) 7 (46.7%) 10 (66.7%)
aet01 can conditionally show the number of withdrawal
Code
cat(export_as_txt(res, lpp = 100))
Output
A: Drug X B: Placebo C: Combination
(N=15) (N=15) (N=15)
—————————————————————————————————————————————————————————————————————————————————————————————————
Total number of patients with at least one AE 13 (86.7%) 14 (93.3%) 15 (100%)
Total number of AEs 58 59 99
Total number of patients with at least one
AE with fatal outcome 8 (53.3%) 8 (53.3%) 10 (66.7%)
Serious AE 12 (80.0%) 12 (80.0%) 11 (73.3%)
Serious AE leading to withdrawal from treatment 0 0 2 (13.3%)
Serious AE leading to dose modification/interruption 4 (26.7%) 3 (20.0%) 4 (26.7%)
Related Serious AE 8 (53.3%) 8 (53.3%) 10 (66.7%)
AE leading to withdrawal from treatment 2 (13.3%) 3 (20.0%) 3 (20.0%)
AE leading to dose modification/interruption 6 (40.0%) 9 (60.0%) 11 (73.3%)
Related AE 11 (73.3%) 10 (66.7%) 13 (86.7%)
Related AE leading to withdrawal from treatment 0 3 (20.0%) 0
Related AE leading to dose modification/interruption 1 (6.7%) 4 (26.7%) 9 (60.0%)
Severe AE (at greatest intensity) 11 (73.3%) 10 (66.7%) 12 (80.0%)
Try the chevron package in your browser
Any scripts or data that you put into this service are public.
chevron documentation built on June 20, 2025, 5:08 p.m.
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
aet01 can handle all NA values
Code
cat(export_as_txt(res, lpp = 100))
Output
A: Drug X B: Placebo C: Combination
(N=15) (N=15) (N=15)
—————————————————————————————————————————————————————————————————————————————————————————————————————
Total number of patients with at least one AE 13 (86.7%) 14 (93.3%) 15 (100%)
Total number of AEs 58 59 99
Total number of deaths 2 (13.3%) 4 (26.7%) 3 (20.0%)
Total number of patients withdrawn from study due to an AE 0 0 1 (6.7%)
Total number of patients with at least one
AE with fatal outcome 0 0 0
Serious AE 0 0 0
Serious AE leading to withdrawal from treatment 0 0 0
Serious AE leading to dose modification/interruption 0 0 0
Related Serious AE 0 0 0
AE leading to withdrawal from treatment 2 (13.3%) 3 (20.0%) 3 (20.0%)
AE leading to dose modification/interruption 6 (40.0%) 9 (60.0%) 11 (73.3%)
Related AE 11 (73.3%) 10 (66.7%) 13 (86.7%)
Related AE leading to withdrawal from treatment 0 3 (20.0%) 0
Related AE leading to dose modification/interruption 1 (6.7%) 4 (26.7%) 9 (60.0%)
Severe AE (at greatest intensity) 11 (73.3%) 10 (66.7%) 12 (80.0%)
Code
cat(export_as_txt(res, lpp = 100))
Output
A: Drug X B: Placebo C: Combination
(N=15) (N=15) (N=15)
—————————————————————————————————————————————————————————————————————————————————————————————————————
Total number of patients with at least one AE 13 (86.7%) 14 (93.3%) 15 (100%)
Total number of AEs 58 59 99
Total number of deaths 2 (13.3%) 4 (26.7%) 3 (20.0%)
Total number of patients withdrawn from study due to an AE 0 0 1 (6.7%)
Total number of patients with at least one
AE leading to withdrawal from treatment 2 (13.3%) 3 (20.0%) 3 (20.0%)
AE leading to dose modification/interruption 6 (40.0%) 9 (60.0%) 11 (73.3%)
Related AE 11 (73.3%) 10 (66.7%) 13 (86.7%)
Related AE leading to withdrawal from treatment 0 3 (20.0%) 0
Related AE leading to dose modification/interruption 1 (6.7%) 4 (26.7%) 9 (60.0%)
Severe AE (at greatest intensity) 11 (73.3%) 10 (66.7%) 12 (80.0%)
aet01 can handle some NA values
Code
cat(export_as_txt(res, lpp = 100))
Output
A: Drug X B: Placebo C: Combination
(N=15) (N=15) (N=15)
—————————————————————————————————————————————————————————————————————————————————————————————————————
Total number of patients with at least one AE 13 (86.7%) 14 (93.3%) 15 (100%)
Total number of AEs 58 59 99
Total number of deaths 2 (13.3%) 4 (26.7%) 3 (20.0%)
Total number of patients withdrawn from study due to an AE 0 0 1 (6.7%)
Total number of patients with at least one
AE with fatal outcome 8 (53.3%) 8 (53.3%) 10 (66.7%)
Serious AE 12 (80.0%) 12 (80.0%) 11 (73.3%)
Serious AE leading to withdrawal from treatment 0 0 2 (13.3%)
Serious AE leading to dose modification/interruption 4 (26.7%) 3 (20.0%) 4 (26.7%)
Related Serious AE 8 (53.3%) 8 (53.3%) 10 (66.7%)
AE leading to withdrawal from treatment 2 (13.3%) 3 (20.0%) 3 (20.0%)
AE leading to dose modification/interruption 6 (40.0%) 9 (60.0%) 11 (73.3%)
Related AE 11 (73.3%) 10 (66.7%) 13 (86.7%)
Related AE leading to withdrawal from treatment 0 3 (20.0%) 0
Related AE leading to dose modification/interruption 1 (6.7%) 4 (26.7%) 9 (60.0%)
Severe AE (at greatest intensity) 11 (73.3%) 10 (66.7%) 12 (80.0%)
aet01 can use custom anl_vars
Code
cat(export_as_txt(res, lpp = 100))
Output
A: Drug X B: Placebo C: Combination
(N=15) (N=15) (N=15)
—————————————————————————————————————————————————————————————————————————————————————————————————————
Total number of patients with at least one AE 13 (86.7%) 14 (93.3%) 15 (100%)
Total number of AEs 58 59 99
Total number of deaths 2 (13.3%) 4 (26.7%) 3 (20.0%)
Total number of patients withdrawn from study due to an AE 0 0 1 (6.7%)
Total number of patients with at least one
AE with fatal outcome 8 (53.3%) 8 (53.3%) 10 (66.7%)
aet01 can use custom medconcept_var
Code
cat(export_as_txt(res, lpp = 100))
Output
A: Drug X B: Placebo C: Combination
(N=15) (N=15) (N=15)
—————————————————————————————————————————————————————————————————————————————————————————————————————
Total number of patients with at least one AE 13 (86.7%) 14 (93.3%) 15 (100%)
Total number of AEs 58 59 99
Total number of deaths 2 (13.3%) 4 (26.7%) 3 (20.0%)
Total number of patients withdrawn from study due to an AE 0 0 1 (6.7%)
Total number of patients with at least one
AE with fatal outcome 8 (53.3%) 8 (53.3%) 10 (66.7%)
Serious AE 12 (80.0%) 12 (80.0%) 11 (73.3%)
Serious AE leading to withdrawal from treatment 0 0 2 (13.3%)
Serious AE leading to dose modification/interruption 4 (26.7%) 3 (20.0%) 4 (26.7%)
Related Serious AE 8 (53.3%) 8 (53.3%) 10 (66.7%)
AE leading to withdrawal from treatment 2 (13.3%) 3 (20.0%) 3 (20.0%)
AE leading to dose modification/interruption 6 (40.0%) 9 (60.0%) 11 (73.3%)
Related AE 11 (73.3%) 10 (66.7%) 13 (86.7%)
Related AE leading to withdrawal from treatment 0 3 (20.0%) 0
Related AE leading to dose modification/interruption 1 (6.7%) 4 (26.7%) 9 (60.0%)
Severe AE (at greatest intensity) 11 (73.3%) 10 (66.7%) 12 (80.0%)
Total number of patients with at least one
SMQ 01 10 (66.7%) 7 (46.7%) 10 (66.7%)
aet01 can conditionally show the number of withdrawal
Code
cat(export_as_txt(res, lpp = 100))
Output
A: Drug X B: Placebo C: Combination
(N=15) (N=15) (N=15)
—————————————————————————————————————————————————————————————————————————————————————————————————
Total number of patients with at least one AE 13 (86.7%) 14 (93.3%) 15 (100%)
Total number of AEs 58 59 99
Total number of patients with at least one
AE with fatal outcome 8 (53.3%) 8 (53.3%) 10 (66.7%)
Serious AE 12 (80.0%) 12 (80.0%) 11 (73.3%)
Serious AE leading to withdrawal from treatment 0 0 2 (13.3%)
Serious AE leading to dose modification/interruption 4 (26.7%) 3 (20.0%) 4 (26.7%)
Related Serious AE 8 (53.3%) 8 (53.3%) 10 (66.7%)
AE leading to withdrawal from treatment 2 (13.3%) 3 (20.0%) 3 (20.0%)
AE leading to dose modification/interruption 6 (40.0%) 9 (60.0%) 11 (73.3%)
Related AE 11 (73.3%) 10 (66.7%) 13 (86.7%)
Related AE leading to withdrawal from treatment 0 3 (20.0%) 0
Related AE leading to dose modification/interruption 1 (6.7%) 4 (26.7%) 9 (60.0%)
Severe AE (at greatest intensity) 11 (73.3%) 10 (66.7%) 12 (80.0%)
Try the chevron package in your browser
Any scripts or data that you put into this service are public.
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
Embedding an R snippet on your website
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.